Your browser doesn't support javascript.
loading
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology.
Finocchiaro, Claudia Yvonne; Rota, Alessandra; Barbieri, Vito; Bettini, Anna; Bianco, Roberto; Borra, Gloria; Buffoni, Lucio; Bulotta, Alessandra; Carta, Annamaria; Cortinovis, Diego; Costanzo, Raffaele; Cusmai, Antonio; Danesi, Romano; D'Argento, Ettore; Del Conte, Alessandro; Franchina, Tindara; Gilli, Marina; Gregorc, Vanesa; Irtelli, Luciana; Landi, Lorenza; Malorgio, Francesco; Mancuso, Gianfranco; Martelli, Olga; Mazzanti, Paola; Melotti, Barbara; Migliorino, Maria Rita; Minotti, Vincenzo; Montrone, Michele; Morabito, Alessandro; Roca, Elisa; Romano, Giampiero; Rossi, Antonio; Savio, Giuseppa; Tiseo, Marcello; Boscardini, Ivano; Piccolo, Lorenzo; Pilotto, Sara; Malapelle, Umberto.
Afiliação
  • Finocchiaro CY; Medica Editoria e Diffusione Scientifica, Milano, Italy.
  • Rota A; Medica Editoria e Diffusione Scientifica, Milano, Italy.
  • Barbieri V; UO Oncologia Medica, AOU "Mater Domini", Germaneto, Catanzaro, Italy.
  • Bettini A; ASST Papa Giovanni XXIII, UO Oncologia, Bergamo, Italy.
  • Bianco R; AOU Federico II, UOC Oncologia Medica, Napoli, Italy.
  • Borra G; AOU Maggiore della Carità di Novara, Novara, Italy.
  • Buffoni L; AOU San Luigi Orbassano, Oncologia Medica, Torino, Italy.
  • Bulotta A; Dipartimento di Oncologia Medica, IRCCS Ospedale Scientifico San Raffaele, Milano, Italy.
  • Carta A; AOB Cagliari, UO Oncologia Medica, Ospedale Businco, Cagliari, Italy.
  • Cortinovis D; Struttura Semplice Lung Unit, Ospedale San Gerardo, ASST Monza, Monza, Italy.
  • Costanzo R; UO Complessa di Oncologia medica Toraco-Polmonare, Istituto Nazionale Tumori, Napoli, Italy.
  • Cusmai A; ASL Bari Ospedale S. Paolo, Bari, Italy.
  • Danesi R; Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Pisa, Italy.
  • D'Argento E; UOC di Oncologia Medica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
  • Del Conte A; IRCCS, Centro di Riferimento Oncologico, SOC Oncologia Medica e dei Tumori Immunocorrelati, Aviano (PN), Italy.
  • Franchina T; Dipartimento di Patologia Umana "G.Barresi", Università degli studi di Messina, Messina, Italy.
  • Gilli M; AORN dei Colli, UOSD DH PNL Oncologico, Napoli, Italy.
  • Gregorc V; Dipartimento di Oncologia Medica, IRCCS Ospedale Scientifico San Raffaele, Milano, Italy.
  • Irtelli L; Clinica Oncologica, ASL Lanciano Vasto Chieti, Chieti, Italy.
  • Landi L; Unità Operativa di Oncologia ed Ematologia, AUSL Romagna, Ravenna, Italy.
  • Malorgio F; Dipartimento di Oncologia, ASL Pescara, Pescara, Italy.
  • Mancuso G; Oncologia Medica, Casa di Cura "La Maddalena", Palermo, Italy.
  • Martelli O; AO Complesso Ospedaliero San Giovanni-Addolorata, Roma, Italy.
  • Mazzanti P; UO Clinica Oncologica, Ospedali Riuniti di Ancona, Ancona, Italy.
  • Melotti B; Oncologia Medica, Azienda Ospedaliera S.Orsola-Malpighi, Bologna, Italy.
  • Migliorino MR; UOSD di Pneumologia Oncologica Azienda Ospedaliera San Camillo-Forlanini, Roma, Italy.
  • Minotti V; Divisione Struttura Complessa Oncologia Medica, Ospedale S. Maria della Misericordia Perugia, Perugia, Italy.
  • Montrone M; SSD Oncologia Medica per la Patologia Toracica, IRCCS Istituto Tumori "Giovanni Paolo II" di Bari, Bari, Italy.
  • Morabito A; Struttura Complessa Oncologia Medica Toraco-Polmonare, Divisione di Oncologia Medica, Istituto Nazionale Tumori Fondazione Pascale, Napoli, Italy.
  • Roca E; Oncologia Medica, Spedali Civili di Brescia, Brescia, Italy.
  • Romano G; UO Oncologia, ASL Lecce, Ospedale "Vito Fazzi", Lecce, Italy.
  • Rossi A; Divisione di Oncologia Medica, Fondazione IRCCS Casa Sollievo della Sofferenza, S. Giovanni Rotondo, Foggia, Italy.
  • Savio G; UO Oncologia, A.R.N.A.S. Civico, Palermo, Italy.
  • Tiseo M; Dipartimento di Medicina e Chirurgia, Università degli Studi di Parma, Parma, Italy.
  • Boscardini I; Docente di tecniche di comunicazione, CREMS Centro di Ricerca in Economia e Management in Sanità e nel Sociale, Università Cattaneo LIUC, Castellanza, VA, Italy.
  • Piccolo L; Reverb Srls, Comunication Section, Milan, Italy.
  • Pilotto S; Università degli Studi di Verona, UO Oncologia Medica, AOUI Verona, Verona, Italy.
  • Malapelle U; Anatomia Patologica, Dip.to di Sanità Pubblica, Università degli Studi di Napoli Federico II, Naples, Italy.
Transl Cancer Res ; 8(Suppl 1): S16-S22, 2019 Jan.
Article em En | MEDLINE | ID: mdl-35117061
ABSTRACT

BACKGROUND:

In the field of oncological assistance, nowadays we have to deal with a complex scenario where patients got used to obtain a huge amount of information through internet or social media and to apply them in performing their health-related decisions. This landscape requires that clinicians become able to handle therapeutical approaches and adequate skills in communication tools to satisfy the current needs. Our project aimed to build a communication model based on clinical oncologists' real experiences in order to find a simple way to share with patients all the innovative therapeutical opportunities today available in lung cancer. The final goal is to design a flexible and personalized model adaptable to clinician's personal characteristics and to the specific patient he is facing. We applied both traditional educational tools and innovative techniques in order to make the results effective and applicable to support peer learning.

METHODS:

The first step consisted in a Board synthesized the definition of the diagnostic process, the identification of treatment strategies and any potential communication barrier clinicians may face dealing with patients. The second step consisted in teamwork including a theoretical part and a training part. In the third step we produce five training videos and video interviews regarding communication praxis and a "Small communication manual". The last step consisted in the publication of the produced material on website and its diffusion through the social media.

RESULTS:

In medicine, the universal application of a single model of communication does not represent the optimal solution. By contrary, the availability of simple and practical suggestions to improve the communicative style could allow clinicians to abandon stereotyped formulas identically repurposed to all patients. The "from bottom to top" training, starting from real-life to take advantage of the clinician's experience, give the clinicians the possibility to meditate about their own communicative style and to train in the context of a protected environment. Applying these rules, we design an effective communication model, based on healthcare humanization, which could represent a fundamental support for the patient in order to be gently driven by the clinician to the most appropriate therapeutical choice, balancing efficacy and quality of life. The relational training may improve the quality of clinician-patient communication and could be widespread to other clinicians through the media.

CONCLUSIONS:

Considering the innovative therapeutical options available, particularly for lung cancer patients, and the increasing access of health-related information through internet or social media the clinician-patient communication has become crucial to support the achievement of the most appropriate therapeutical choice for the patient, facing the intricate illness experience. Building a shareable and easy-to-apply communication model represents a challenge aimed to help clinicians and including technology not as a threat, but as a positive tool.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article